Imaging for staging bladder cancer: a clinical study of intravenous ¹¹¹ indium‐labelled anti‐MUC1 mucin monoclonal antibody C595

Abstract

This study confirmed the ability of the mAb technique to detect both primary and recurrent invasive bladder tumours and distant metastases. Some lesions shown by mAb imaging were not detected by other methods. The use of mAb imaging has the potential to improve clinical staging and assist in selecting those patients most likely to benefit from radical therapy.